The information on this page does not contain a record of our trading prices, or an offer of, or solicitation for, a transaction in any financial instrument. IG accepts no responsibility for any use that may be made of these comments and for any consequences that result. No representation or warranty is given as to the accuracy or completeness of this information. Consequently any person acting on it does so entirely at their own risk. Any research provided does not have regard to the specific investment objectives, financial situation and needs of any specific person who may receive it and as such is considered to be a marketing communication.
I will not go into detail for each stock, but there are three in this list that should be noted. Caracal, Heritage Oil and Smith & Nephew have all been the target of bid approaches. A similar situation was seen with AstraZeneca last month. These shares have been rapidly pushed higher, but if the bid fails to materialize, as happened with Astra, the shares can drop back. Thus I would look to exclude these from the strategy.